TAKEDA PHARMA A/S

Elaine Shannon

Global Quality Officer

Christophe Weber

Representative Director - President & CEO

Julie Kim

CEO-Elect

Laura Nocerino

Rare Business Unit Head

Akiko Amakawa

Corporate Strategy Officer & CEO Chief of Staff

Phil Rowlands

Head, Oncology Therapeutic Area Unit

Teresa Bitetti

President, Global Oncology, Takeda

Lauren Duprey

Chief Human Resources Officer

Gabriele Ricci

Chief Data & Technology Officer

Chris Arendt

Head, Oncology Drug Discovery Unit

Andy Plump

President, R&D

Christopher Morabito

Head, R&D, Plasma-Derived Therapies

Milano Furuta

Director – Chief Financial Officer

Sheelagh Cawley-Knopf

Head, R&D Global Portfolio Strategy

Masami Iijima

Chair of the Board of Directors

Asuka Miyabashira

President, Japan Pharma Business Unit

Natalie Furney

Global General Counsel

Sameh Rafla

General Manager

Marcello Agosti

Global Business Development Officer

Nicola Greenway

Chief Human Resources Officer

Christophe Bianchi

President, Global Oncology Business Unit

Rhonda Pacheco

President, U.S. Business Unit and U.S. Country Head

Dan Curran

Head, Rare Disease Therapeutic Area Unit

Ramy Riad

President, Plasma-Derived Therapies Business Unit

Awny Farajallah

Chief Medical Officer

Asit Parikh

Head, GI Therapeutic Area Unit

Giles Platford

President, Plasma-Derived Therapies Business Unit

Andrew S. Plump

Director - President, Research & Development

Anna Maria Bencini

Chairman of the Board and CEO

Elke Michiels

Ethics and Collaboration

Lamia Masmoudi

Medical Affairs Director

Rachael Brake

Global Program Leader, Oncology

Carlos Soto

Covington Site Head

Deborah Hartman

Global Program Leader, Neuroscience

Joachim Henriksen

Press Contact

Ricky Verheijen

Logistics

Camille Penven

Communication Manager